SK

Samarth Kulkarni

Chief Executive Officer

CRISPR Therapeutics


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
CRISPR Therapeutics
Industry
research
Employees
410.0
Seniority
C suite
Annual Revenue
37300000.0

Professional Summary

Samarth Kulkarni serves as Chief Executive Officer at CRISPR Therapeutics. CRISPR Therapeutics operates in the research sector with approximately 410.0 employees. CRISPR Therapeutics generates annual revenue of 37300000.0.

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • Our database includes 201,469 c suite-level executives.

Technologies

Microsoft Office 365 Drupal Oracle Cloud Citrix NetScaler ServiceNow Nginx Vimeo Google Analytics Mobile Friendly Typekit New Relic Google Tag Manager Remote AI

Keywords

gene editing hematology immunooncology biotechnology: biological products (no diagnostic substances) health care biotechnology research crispr bioengineering cell therapy hemoglobinopathies sickle cell disease beta thalassemia immuno-oncology autoimmune diseases in vivo regenerative medicine crispr/cas9 therapeutics patient advocacy clinical trials investigational medicines precision medicine biotechnology genetic diseases patient engagement clinical research gene therapies ex vivo transformative therapies bioethical practices partnerships research collaboration scalable manufacturing genome editing gmp facilities molecular biology therapeutic pipelines fda approval disease modification genetic engineering patient-centered care nobel prize scientific innovation healthcare disparities diversity in biotech community engagement market access health equity community awareness regulatory compliance drug development biopharma investor relations clinical development intellectual property crispr/cas9 technology transformative medicines beta-thalassemia car-t cell therapy cardiovascular diseases genetic disorders personalized treatment pharmaceutical industry patient-centric approach strategic partnerships vertex pharmaceuticals nkarta therapeutics casebia therapeutics innovative therapies rare diseases healthcare professionals genetic counselors biotechnology collaborations market expansion in vivo programs advanced genetic engineering patient outcomes healthcare innovation transformative gene-based therapies health wellness & fitness hospital & health care

Related Executives

SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands
IT
Ilia Tikhomirov Chief Executive Officer at 35Pharma
AD
Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Frequently Asked Questions

How can I contact Samarth Kulkarni?

Samarth Kulkarni's verified email address is available on MessageCEO. They currently work at CRISPR Therapeutics. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Samarth Kulkarni lead?

Samarth Kulkarni is Chief Executive Officer at CRISPR Therapeutics, a company in the research sector with 410.0 employees.

What industry is Samarth Kulkarni in?

Samarth Kulkarni works in the research industry as Chief Executive Officer at CRISPR Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Samarth Kulkarni's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Samarth Kulkarni's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: April 12, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans